Tumor-infiltrating CD8+ T cells, for example, act cytotoxic and have been shown to be associated with a better prognosis in different malignancies including HPV-positive and -negative HNSCC [14–16]. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.